Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1984 2
1986 1
1989 2
1990 1
1993 1
1999 1
2001 1
2006 1
2007 1
2009 1
2010 1
2011 3
2012 1
2013 1
2014 1
2015 1
2019 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.
Ramos EL, Dayan CM, Chatenoud L, Sumnik Z, Simmons KM, Szypowska A, Gitelman SE, Knecht LA, Niemoeller E, Tian W, Herold KC; PROTECT Study Investigators. Ramos EL, et al. N Engl J Med. 2023 Dec 7;389(23):2151-2161. doi: 10.1056/NEJMoa2308743. Epub 2023 Oct 18. N Engl J Med. 2023. PMID: 37861217 Clinical Trial.
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators. Tamborlane WV, et al. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. N Engl J Med. 2019. PMID: 31034184 Clinical Trial.
Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes.
Philotheou A, Arslanian S, Blatniczky L, Peterkova V, Souhami E, Danne T. Philotheou A, et al. Among authors: blatniczky l. Diabetes Technol Ther. 2011 Mar;13(3):327-34. doi: 10.1089/dia.2010.0072. Epub 2011 Feb 3. Diabetes Technol Ther. 2011. PMID: 21291333 Free PMC article. Clinical Trial.
The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients.
Laki J, Kiszel P, Vatay A, Blaskó B, Kovács M, Körner A, Madácsy L, Blatniczky L, Almássy Z, Szalai C, Rajczy K, Pozsonyi E, Karádi I, Fazakas A, Hosszúfalusi N, Pánczél P, Arason GJ, Wu YL, Zhou B, Yang Y, Yu CY, Füst G. Laki J, et al. Among authors: blatniczky l. Mol Immunol. 2007 Jan;44(4):648-55. doi: 10.1016/j.molimm.2006.01.011. Epub 2006 Feb 28. Mol Immunol. 2007. PMID: 16504296
[Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L. Pánczél P, et al. Among authors: blatniczky l. Orv Hetil. 1999 Nov 28;140(48):2695-701. Orv Hetil. 1999. PMID: 10645715 Clinical Trial. Hungarian.
21 results